Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2011, Article ID 160967, 6 pages
http://dx.doi.org/10.1155/2011/160967
Research Article

Effects of Polyethylene Glycol Spacer Length and Ligand Density on Folate Receptor Targeting of Liposomal Doxorubicin In Vitro

Institute of Medicinal Chemistry, Hoshi University, Ebara 2-4-41, Shinagawa-ku, Tokyo 142-8501, Japan

Received 1 July 2010; Revised 22 November 2010; Accepted 22 November 2010

Academic Editor: Sophia Antimisiaris

Copyright © 2011 Kumi Kawano and Yoshie Maitani. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Cho, XU. Wang, S. Nie, Z. Chen, and D. M. Shin, “Therapeutic nanoparticles for drug delivery in cancer,” Clinical Cancer Research, vol. 14, no. 5, pp. 1310–1316, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S. D. Weitman, R. H. Lark, L. R. Coney et al., “Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues,” Cancer Research, vol. 52, no. 12, pp. 3396–3401, 1992. View at Google Scholar · View at Scopus
  3. M. Wu, W. Gunning, and M. Ratnam, “Expression of folate receptor type α in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix,” Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 9, pp. 775–782, 1999. View at Google Scholar · View at Scopus
  4. N. Parker, M. J. Turk, E. Westrick, J. D. Lewis, P. S. Low, and C. P. Leamon, “Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay,” Analytical Biochemistry, vol. 338, no. 2, pp. 284–293, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. S. Wang and P. S. Low, “Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells,” Journal of Controlled Release, vol. 53, no. 1–3, pp. 39–48, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Q. Pan, H. Wang, and R. J. Lee, “Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model,” Pharmaceutical Research, vol. 20, no. 3, pp. 417–422, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. W. A. Henne, D. D. Doorneweerd, A. R. Hilgenbrink, S. A. Kularatne, and P. S. Low, “Synthesis and activity of a folate peptide camptothecin prodrug,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 20, pp. 5350–5355, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. Y. Bae, N. Nishiyama, and K. Kataoka, “In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments,” Bioconjugate Chemistry, vol. 18, no. 4, pp. 1131–1139, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. R. J. Lee and P. S. Low, “Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro,” Biochimica et Biophysica Acta, vol. 1233, no. 2, pp. 134–144, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Reddy, C. Abburi, H. Hofland et al., “Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors,” Gene Therapy, vol. 9, no. 22, pp. 1542–1560, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. M. Saul, A. Annapragada, J. V. Natarajan, and R. V. Bellamkonda, “Controlled targeting of liposomal doxorubicin via the folate receptor in vitro,” Journal of Controlled Release, vol. 92, no. 1-2, pp. 49–67, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Shmeeda, L. Mak, D. Tzemach, P. Astrahan, M. Tarshish, and A. Gabizon, “Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors,” Molecular Cancer Therapeutics, vol. 5, no. 4, pp. 818–824, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. A. Gabizon, A. T. Horowitz, D. Goren et al., “Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies,” Bioconjugate Chemistry, vol. 10, no. 2, pp. 289–298, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. C. P. Leamon and J. A. Reddy, “Folate-targeted chemotherapy,” Advanced Drug Delivery Reviews, vol. 56, no. 8, pp. 1127–1141, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. T. Shiokawa, Y. Hattori, K. Kawano et al., “Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycln a on targeting ability and antitumor effect in vitro and in vivo,” Clinical Cancer Research, vol. 11, no. 5, pp. 2018–2025, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. B. C. L. Cheung, T. H. T. Sun, J. M. Leenhouts, and P. R. Cullis, “Loading of doxorubicin into liposomes by forming Mn-drug complexes,” Biochimica et Biophysica Acta, vol. 1414, no. 1-2, pp. 205–216, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Abraham, K. Edwards, G. Karlsson et al., “Formation of transition metal-doxorubicin complexes inside liposomes,” Biochimica et Biophysica Acta, vol. 1565, no. 1, pp. 41–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Li, D. J. Hirsh, D. Cabral-Lilly et al., “Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient,” Biochimica et Biophysica Acta, vol. 1415, no. 1, pp. 23–40, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. P. S. Uster, T. M. Allen, B. E. Daniel, C. J. Mendez, M. S. Newman, and G. Z. Zhu, “Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time,” FEBS Letters, vol. 386, no. 2-3, pp. 243–246, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Kirchmeier, T. Ishida, J. Chevrette, and T. M. Allen, “Correlations between the rate of intracellular release of endocytosed liposomal doxorubicin and cytotoxicity as determined by a new assay,” Journal of Liposome Research, vol. 11, no. 1, pp. 15–29, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. M. J. W. Johnston, S. C. Semple, S. K. Klimuk et al., “Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations,” Biochimica et Biophysica Acta, vol. 1758, no. 1, pp. 55–64, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus